Literature DB >> 33027081

Empagliflozin Eliminates Refractory Ascites and Hepatic Hydrothorax in a Patient With Primary Biliary Cirrhosis.

Georgios N Kalambokis1, Ilias Tsiakas, Sebastien Filippas-Ntekuan, Maria Christaki, Grigorios Despotis, Haralampos Milionis.   

Abstract

Entities:  

Year:  2021        PMID: 33027081     DOI: 10.14309/ajg.0000000000000995

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

Review 1.  Management of Portal Hypertension.

Authors:  Anand V Kulkarni; Atoosa Rabiee; Arpan Mohanty
Journal:  J Clin Exp Hepatol       Date:  2022-03-21

2.  SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites.

Authors:  Yuan Gao; Lai Wei; Dorothy Da Zhang; Yu Chen; Bing Hou
Journal:  J Clin Transl Hepatol       Date:  2021-11-26

3.  Weaning from concentrated ascites reinfusion therapy for refractory ascites by SGLT2 inhibitor.

Authors:  Yasunori Miyamoto; Akira Honda; Seiji Yokose; Mariko Nagata; Jiro Miyamoto
Journal:  Clin Kidney J       Date:  2021-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.